Vesela Karamisheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vesela Karamisheva has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Liliya Koleva
Clinic of Operative Gynecology, University Hospital “Pirogov”-Sofia, 1606 Sofia, Bulgaria
5 shared publications - Victoria Spasova
Medical University of Sofia, Bulgaria
4 shared publications - Anatoli Kolev
Faculty of Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria
2 shared publications - Anatoli Kolev
Medical University of Sofia, Bulgaria
2 shared publications - Bozhidar Karamishev
Faculty of Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria
2 shared publications - Daria Koleva
Faculty of Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria
2 shared publications
Latest Publications
- Open Access
- 14 July 2026
- Published by IntechOpen
Perspective Chapter: Endometriosis – Challenges in Diagnosis and Treatment – Status and Future Perspectives
Endometriosis (EM) is a chronic, estrogen-dependent, inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus. It is estimated that EM occurs in approximately 10% of women of the reproductive age and is associated with severe morbidity in the form of chronic pelvic pain and subfertility. Diagnosis is challenging due to nonspecific symptoms, long diagnosis-to-treatment times (4–11 years), the inability of imaging techniques to accurately locate superficial lesions, and the lack of validated noninvasive biomarkers. The latest European Society of Human Reproduction and Embryology (ESHRE) and American College of Obstetricians and Gynecologists (ACOG) guidelines no longer consider laparoscopy as the reference standard test. Presently, the management of EM is focused on symptom control using hormones (such as combined oral contraceptives, progestins, and gonadotropin-releasing hormone analogs) and surgery in non-responders or for fertility preservation. However, EM is highly recurrent, with recurrence rates of up to 50% at five years after treatment, associated with numerous side effects and limited improvement in fertility preservation rates. Precision medicine for EM will require the identification of multiomic biomarkers of the disease to develop non-invasive approaches for the diagnosis and management of EM using artificial intelligence-based imaging technologies and novel immunomodulatory drugs.
- 14 July 2026
- Published by IntechOpen
Open AccessPerspective Chapter: Endometriosis – Challenges in Diagnosis and Treatment – Status and Future Perspectives
Endometriosis (EM) is a chronic, estrogen-dependent, inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus. It is estimated that EM occurs in approximately 10% of women of the reproductive age and is associated with severe morbidity in the form of chronic pelvic pain and subfertility. Diagnosis is challenging due to nonspecific symptoms, long diagnosis-to-treatment times (4–11 years), the inability of imaging techniques to accurately locate superficial lesions, and the lack of validated noninvasive biomarkers. The latest European Society of Human Reproduction and Embryology (ESHRE) and American College of Obstetricians and Gynecologists (ACOG) guidelines no longer consider laparoscopy as the reference standard test. Presently, the management of EM is focused on symptom control using hormones (such as combined oral contraceptives, progestins, and gonadotropin-releasing hormone analogs) and surgery in non-responders or for fertility preservation. However, EM is highly recurrent, with recurrence rates of up to 50% at five years after treatment, associated with numerous side effects and limited improvement in fertility preservation rates. Precision medicine for EM will require the identification of multiomic biomarkers of the disease to develop non-invasive approaches for the diagnosis and management of EM using artificial intelligence-based imaging technologies and novel immunomodulatory drugs.
- Open Access
Specific IgE/IgG in Umbilical Cord Blood and Maternal Blood in Mothers with Eosinophilia
Background: Presence of milk, fruits, eggs, fish, nuts and wheat antigens in the amniotic fluid is described in the literature. Studies show a contradictory relationship between maternal exposure to allergens and early sensitization of the fetus to allergens. Hemochorionic type of the human placenta allows for easier transfer of nutrients and antibodies from the mother’s blood to the fetal circulation through the direct contact of maternal blood with the fetal chorion. During the third trimester of pregnancy, immunoglobulin G (IgG) is actively transferred through the placenta into the fetal via neonatal FcRN receptor (FcRN). In addition, monomeric immunoglobulin E (IgE) cannot cross the placenta Aim: The objective of our study is to track intrauterine sensitization to essential food proteins at birth in umbilical cord blood in mothers with established peripheral blood eosinophilia and in their infants using allergen-specific IgE and IgG. Methods: An observational study was carried out in a cohort of 22 mothers with eosinophilia and their babies. Differences in expression between groups were assessed. Blood samples were collected to determine serum IgE and IgG specific to a set of inhalant and food allergens. Results: We did not find a significant correlation between specific IgE to cow’s milk (p = 0.857), egg white (p = 0.926) and egg yolk (p = 0.096) in umbilical cord blood and maternal blood samples taken immediately before birth. Spearman’s correlation of the specific IgE and IgG in umbilical cord blood showed no dependence between the two variables. In contrast, statistical analysis showed that maternal eosinophilia in peripheral blood could be a risk factor for the development of allergy in the offspring (χ2, p = 0.0347). However, given the small number of patients, this claim needs to be confirmed with further studies. Conclusions: Due to the functional immaturity of the developing immune system of the fetus, the generation and maintenance of an independent immune response to allergens are incomplete. Maternal IgG (specific) passes to the baby and high maternal IG to a specific allergen reduces babies IgE production. In addition, low maternal specific IgG may promote IgE production in the baby under the influence of microenvironmental factors (cytokine background). The main limitation of our study is the small number of patients. Further research is needed in this direction to clarify the mechanisms and risk factors for early sensitization in newborns.
Open AccessSpecific IgE/IgG in Umbilical Cord Blood and Maternal Blood in Mothers with Eosinophilia
Background: Presence of milk, fruits, eggs, fish, nuts and wheat antigens in the amniotic fluid is described in the literature. Studies show a contradictory relationship between maternal exposure to allergens and early sensitization of the fetus to allergens. Hemochorionic type of the human placenta allows for easier transfer of nutrients and antibodies from the mother’s blood to the fetal circulation through the direct contact of maternal blood with the fetal chorion. During the third trimester of pregnancy, immunoglobulin G (IgG) is actively transferred through the placenta into the fetal via neonatal FcRN receptor (FcRN). In addition, monomeric immunoglobulin E (IgE) cannot cross the placenta Aim: The objective of our study is to track intrauterine sensitization to essential food proteins at birth in umbilical cord blood in mothers with established peripheral blood eosinophilia and in their infants using allergen-specific IgE and IgG. Methods: An observational study was carried out in a cohort of 22 mothers with eosinophilia and their babies. Differences in expression between groups were assessed. Blood samples were collected to determine serum IgE and IgG specific to a set of inhalant and food allergens. Results: We did not find a significant correlation between specific IgE to cow’s milk (p = 0.857), egg white (p = 0.926) and egg yolk (p = 0.096) in umbilical cord blood and maternal blood samples taken immediately before birth. Spearman’s correlation of the specific IgE and IgG in umbilical cord blood showed no dependence between the two variables. In contrast, statistical analysis showed that maternal eosinophilia in peripheral blood could be a risk factor for the development of allergy in the offspring (χ2, p = 0.0347). However, given the small number of patients, this claim needs to be confirmed with further studies. Conclusions: Due to the functional immaturity of the developing immune system of the fetus, the generation and maintenance of an independent immune response to allergens are incomplete. Maternal IgG (specific) passes to the baby and high maternal IG to a specific allergen reduces babies IgE production. In addition, low maternal specific IgG may promote IgE production in the baby under the influence of microenvironmental factors (cytokine background). The main limitation of our study is the small number of patients. Further research is needed in this direction to clarify the mechanisms and risk factors for early sensitization in newborns.
- Open Access
- 25 August 2025
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 78 (8)
MicroRNAs as Diagnostic Biomarkers for Liver Fibrosis in Chronic Hepatitis B: Insights from Expression Profiling and Correlations with Fibrosis Stages
Chronic hepatitis B (CHB) infection remains a significant global health challenge, leading to severe liver complications such as cirrhosis and hepatocellular carcinoma (HCC), which makes accurate fibrosis assessment crucial for prognosis and treatment. This study investigated the expression levels of five miRNAs (hsa-miR-21-3p, hsa-miR-29a-3p, hsa-miR-122-3p, hsa-miR-221-3p, and hsa-miR-222-3p) in 40 CHB patients classified into mild-to-moderate (F1-F2) and severe fibrosis (F3-F4) groups using transient elastography. Quantitative PCR analysis revealed that hsa-miR-29a-3p ($$r=0.72$$, $$p<0.001$$), was upregulated, while hsa-miR-21-3p ($$r=-0.65$$, $$p<0.01$$) and hsa-miR-122-3p ($$r=-0.68$$, $$p<0.01$$,) were downregulated in severe fibrosis. Combining hsa-miR-29a-3p (AUC=0.89, 95% CI: 0.84–0.94) and hsa-miR-21-3p (AUC=0.87, 95% CI: 0.82–0.93) in a predictive model improved diagnostic accuracy. These findings highlight the potential of miRNA profiling to enhance current diagnostic algorithms. Further studies in larger cohorts are needed to validate their role in fibrosis assessment and disease monitoring.- 25 August 2025
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 78 (8)
Open AccessMicroRNAs as Diagnostic Biomarkers for Liver Fibrosis in Chronic Hepatitis B: Insights from Expression Profiling and Correlations with Fibrosis Stages
Chronic hepatitis B (CHB) infection remains a significant global health challenge, leading to severe liver complications such as cirrhosis and hepatocellular carcinoma (HCC), which makes accurate fibrosis assessment crucial for prognosis and treatment. This study investigated the expression levels of five miRNAs (hsa-miR-21-3p, hsa-miR-29a-3p, hsa-miR-122-3p, hsa-miR-221-3p, and hsa-miR-222-3p) in 40 CHB patients classified into mild-to-moderate (F1-F2) and severe fibrosis (F3-F4) groups using transient elastography. Quantitative PCR analysis revealed that hsa-miR-29a-3p ($$r=0.72$$, $$p<0.001$$), was upregulated, while hsa-miR-21-3p ($$r=-0.65$$, $$p<0.01$$) and hsa-miR-122-3p ($$r=-0.68$$, $$p<0.01$$,) were downregulated in severe fibrosis. Combining hsa-miR-29a-3p (AUC=0.89, 95% CI: 0.84–0.94) and hsa-miR-21-3p (AUC=0.87, 95% CI: 0.82–0.93) in a predictive model improved diagnostic accuracy. These findings highlight the potential of miRNA profiling to enhance current diagnostic algorithms. Further studies in larger cohorts are needed to validate their role in fibrosis assessment and disease monitoring. - Open Access
- 17 July 2025
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 78 (7)
Screening for Thyroid Disorders in the First Trimester of Pregnancy
Screening for thyroid disorders during pregnancy is an essential method of detection and could prevent maternal and foetal complications to a considerable extent. The aim of this study was to establish the prevalence of hypothyroidism in pregnancy and to compare universal, targeted and no screening. A prospective-retrospective study was conducted at Neoclinic Medical Centre and University Obstetrics and Gynaecology Hospital “Maichin Dom” between 2018 and 2020 in 420 pregnant women. It was conducted in two parts, with the first part (133 subjects) involving universal screening in the first trimester of newly registered pregnant women during their first obstetrician-gynaecologist visit, and the second part (287 subjects) involving patients in the third trimester who had been screened for thyroid-stimulating hormone (TSH) during pregnancy, with the screening reasons being later on analyzed and, respectively, whether the patients were covered by screening and with what type of screening the patients with thyroid disorder would have been diagnosed. TSH was tested in all patients, and a value of 2.5 mIU/L was accepted as the upper limit of normal for the screening in the first trimester. We found hypothyroidism in 28.6% (38/133) of the patients using universal screening. At least one criterion for increased risk of developing thyroid disorder during pregnancy was present in 78.9% (30/38). Thus, a targeted screening would miss 21.1% (8/38) of the patients in risk. In the second part of the study, the disease was detected in 65.51% (188/287) by either prophylactic testing or universal screening during pregnancy; 31.36% (90/287) of the subjects were diagnosed due to clinical suspicion and 3.13% (9/287) due to family history. Eighty per cent (153/190) of the patients with hypothyroidism were high-risk with the most common criteria being: age above 30 – 63.2% (120/190), autoimmune co-morbidity – 35.8% (68/190) and personal history of miscarriage – 31.1% (59/190). Targeted screening would miss 19.5% (37/190) of them. Most of the patients with clinical hypothyroidism (49/64) would have been classified as high-risk had they been screened universally and therefore 23.4% (15/64) would have been missed in a targeted screening. About 21.1% (8/38) of the patients with hypothyroidism would have been missed with targeted screening and between 28.6% (38/133) and 65.51% (188/287) in the absence of any screening suggesting the need of universal screening establishment at the first visit to an obstetrician-gynaecologist.
- 17 July 2025
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 78 (7)
Open AccessScreening for Thyroid Disorders in the First Trimester of Pregnancy
Screening for thyroid disorders during pregnancy is an essential method of detection and could prevent maternal and foetal complications to a considerable extent. The aim of this study was to establish the prevalence of hypothyroidism in pregnancy and to compare universal, targeted and no screening. A prospective-retrospective study was conducted at Neoclinic Medical Centre and University Obstetrics and Gynaecology Hospital “Maichin Dom” between 2018 and 2020 in 420 pregnant women. It was conducted in two parts, with the first part (133 subjects) involving universal screening in the first trimester of newly registered pregnant women during their first obstetrician-gynaecologist visit, and the second part (287 subjects) involving patients in the third trimester who had been screened for thyroid-stimulating hormone (TSH) during pregnancy, with the screening reasons being later on analyzed and, respectively, whether the patients were covered by screening and with what type of screening the patients with thyroid disorder would have been diagnosed. TSH was tested in all patients, and a value of 2.5 mIU/L was accepted as the upper limit of normal for the screening in the first trimester. We found hypothyroidism in 28.6% (38/133) of the patients using universal screening. At least one criterion for increased risk of developing thyroid disorder during pregnancy was present in 78.9% (30/38). Thus, a targeted screening would miss 21.1% (8/38) of the patients in risk. In the second part of the study, the disease was detected in 65.51% (188/287) by either prophylactic testing or universal screening during pregnancy; 31.36% (90/287) of the subjects were diagnosed due to clinical suspicion and 3.13% (9/287) due to family history. Eighty per cent (153/190) of the patients with hypothyroidism were high-risk with the most common criteria being: age above 30 – 63.2% (120/190), autoimmune co-morbidity – 35.8% (68/190) and personal history of miscarriage – 31.1% (59/190). Targeted screening would miss 19.5% (37/190) of them. Most of the patients with clinical hypothyroidism (49/64) would have been classified as high-risk had they been screened universally and therefore 23.4% (15/64) would have been missed in a targeted screening. About 21.1% (8/38) of the patients with hypothyroidism would have been missed with targeted screening and between 28.6% (38/133) and 65.51% (188/287) in the absence of any screening suggesting the need of universal screening establishment at the first visit to an obstetrician-gynaecologist.
- Open Access
- 25 December 2024
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 77 (12) , 1808-1816
Circulating miRNAs – a Potential Non-invasive Biomarker for Diagnosis of Endometriosis
Endometriosis is a debilitating disease affecting one in ten women worldwide. Due to several reasons the diagnosis is delayed for 7–11 years. Currently, the ultimate diagnostic procedure is laparoscopy followed by histological examination. The need for non-invasive biomarker is placed as a top priority according to the World Endometriosis Society. The present study includes 45 females – 30 patients with endometriosis at different stages and 15 healthy controls. An expression analysis of 84 circulating miRNAs was performed comparing between different groups of participants. Ten miRNAs with the most significant expression difference between females at early stage of endometriosis, advanced stage of endometriosis and healthy controls were nominated as a potential diagnostic and prognostic biomarker using a panel of miRNAs.
- 25 December 2024
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 77 (12) , 1808-1816
Open AccessCirculating miRNAs – a Potential Non-invasive Biomarker for Diagnosis of Endometriosis
Endometriosis is a debilitating disease affecting one in ten women worldwide. Due to several reasons the diagnosis is delayed for 7–11 years. Currently, the ultimate diagnostic procedure is laparoscopy followed by histological examination. The need for non-invasive biomarker is placed as a top priority according to the World Endometriosis Society. The present study includes 45 females – 30 patients with endometriosis at different stages and 15 healthy controls. An expression analysis of 84 circulating miRNAs was performed comparing between different groups of participants. Ten miRNAs with the most significant expression difference between females at early stage of endometriosis, advanced stage of endometriosis and healthy controls were nominated as a potential diagnostic and prognostic biomarker using a panel of miRNAs.
- Open Access
- 21 December 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (1) , rjae833
Two cases of giant mucinous cystadenomas in postmenopausal women
Mucinous ovarian cystadenomas are rare epithelial benign tumors that can reach significant sizes. They are often asymptomatic and are discovered incidentally during an ultrasound examination. We present two clinical cases of mucinous ovarian cystadenomas with abdominal distention. Complicated variants can mimic an acute surgical abdomen and often require the involvement of a multidisciplinary team in operative treatment. Timely diagnosis and treatment are of utmost importance to prevent complications and malignancy.
- 21 December 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (1) , rjae833
Open AccessTwo cases of giant mucinous cystadenomas in postmenopausal women
Mucinous ovarian cystadenomas are rare epithelial benign tumors that can reach significant sizes. They are often asymptomatic and are discovered incidentally during an ultrasound examination. We present two clinical cases of mucinous ovarian cystadenomas with abdominal distention. Complicated variants can mimic an acute surgical abdomen and often require the involvement of a multidisciplinary team in operative treatment. Timely diagnosis and treatment are of utmost importance to prevent complications and malignancy.
- Open Access
- 31 October 2023
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 76 (10) , 1601-1608
MiRNA Expression Profiles in an Ectopic Endometrium of Patients at Different Stage of Endometriosis
Endometriosis is a debilitating disease that affects up to 15% of women worldwide. Delayed diagnosis, lack of noninvasive biomarker and unexplained pathogenesis are key problems for specialists and patients alike. MiRNAs are a class of noncoding RNAs that regulate myriad of cellular functions. These gene expression regulators may prove to be attractive biomarkers with diagnostic and prognostic value for endometriosis. Tissue samples were collected from the participants enrolled in the study during laparoscopy (patients) and hysteroscopy (control group). After RNA isolation (miRNeasy MiniKit, Qiagen) based on the disease stage, three pools – each containing 15 RNA samples, were constructed: 1) early stage endometriosis, 2) late stage endometriosis, and 3) healthy controls. Each pool sample was subjected to reverse transcription via miScript II RT Kit, Qiagen to obtain cDNA. SYBR Green based Real-time PCR assay was used to determine the expression profile of 84 miRNAs (Human miFinder miRNA PCR Array, Qiagen). We detected 32 differently expressed miRNAs between early stage endometriosis and control group, and 51 differently expressed miRNAs between advanced stage endometriosis and control group. Three miRNAs were differentially expressed with more than 10-fold change in the early stage group and thn miRNAs showed more than 10-fold change in the advanced stages group. The three miRNAs with the highest fold change in the expression levels in both case groups were nominated as potential biomarkers for endometriosis. The results of the analysis of their target genes supports the role of deregulation of apoptosis, angiogenesis, epithelial-mesenchymal transition, and various other cellular signalling pathways in endometriosis development.
- 31 October 2023
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 76 (10) , 1601-1608
Open AccessMiRNA Expression Profiles in an Ectopic Endometrium of Patients at Different Stage of Endometriosis
Endometriosis is a debilitating disease that affects up to 15% of women worldwide. Delayed diagnosis, lack of noninvasive biomarker and unexplained pathogenesis are key problems for specialists and patients alike. MiRNAs are a class of noncoding RNAs that regulate myriad of cellular functions. These gene expression regulators may prove to be attractive biomarkers with diagnostic and prognostic value for endometriosis. Tissue samples were collected from the participants enrolled in the study during laparoscopy (patients) and hysteroscopy (control group). After RNA isolation (miRNeasy MiniKit, Qiagen) based on the disease stage, three pools – each containing 15 RNA samples, were constructed: 1) early stage endometriosis, 2) late stage endometriosis, and 3) healthy controls. Each pool sample was subjected to reverse transcription via miScript II RT Kit, Qiagen to obtain cDNA. SYBR Green based Real-time PCR assay was used to determine the expression profile of 84 miRNAs (Human miFinder miRNA PCR Array, Qiagen). We detected 32 differently expressed miRNAs between early stage endometriosis and control group, and 51 differently expressed miRNAs between advanced stage endometriosis and control group. Three miRNAs were differentially expressed with more than 10-fold change in the early stage group and thn miRNAs showed more than 10-fold change in the advanced stages group. The three miRNAs with the highest fold change in the expression levels in both case groups were nominated as potential biomarkers for endometriosis. The results of the analysis of their target genes supports the role of deregulation of apoptosis, angiogenesis, epithelial-mesenchymal transition, and various other cellular signalling pathways in endometriosis development.
- 30 April 2023
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 76 (4) , 622-628
Vitamin D Status in Term Newborns and Their Mothers
- 30 April 2023
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 76 (4) , 622-628
Vitamin D Status in Term Newborns and Their Mothers